Candidiasis y otras enfermedades infecciosas asociadas con biopelículas (CanBIO) - GIC 21/024
Instituto de Investigación Sanitaria La Fe
Valencia, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria La Fe (11)
2024
2022
-
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Frontiers in Cellular and Infection Microbiology, Vol. 12
2021
-
Identification of Candida auris and related species by multiplex PCR based on unique GPI protein-encoding genes
Mycoses, Vol. 64, Núm. 2, pp. 194-202
-
In vitro pharmacokinetic/pharmacodynamic modelling and simulation of amphotericin b against candida auris
Pharmaceutics, Vol. 13, Núm. 11
2020
-
Fungal co-infection in COVID-19 patients: Should we be concerned?
Revista Iberoamericana de Micologia
-
Utility of two PCR-RFLP-based techniques for identification of Candida parapsilosis complex blood isolates
Mycoses, Vol. 63, Núm. 5, pp. 461-470
2019
-
Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity
Revista Iberoamericana de Micologia, Vol. 36, Núm. 1, pp. 24-29
-
Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 1
2018
-
Molecular identification of Candida auris by PCR amplification of species-specific GPI protein-encoding genes
International Journal of Medical Microbiology, Vol. 308, Núm. 7, pp. 812-818
2015
-
Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves
Diagnostic Microbiology and Infectious Disease, Vol. 82, Núm. 1, pp. 57-61
-
In Vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies
Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 6, pp. 3615-3618